Danazol Mechanisms of Action
Danazol acts primarily by suppressing the pituitary-ovarian axis through multiple mechanisms: it depresses FSH and LH secretion, binds directly to sex steroid receptors (androgen, progesterone, and estrogen receptors) in target tissues, alters sex steroid metabolism, and exhibits weak androgenic activity. 1
Primary Hormonal Mechanisms
The drug operates through a combination of central and peripheral effects:
Pituitary suppression: Danazol depresses both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) output, creating a hypoestrogenic state 1
Direct gonadal inhibition: Evidence demonstrates direct inhibitory effects at gonadal sites, independent of pituitary suppression 1
Steroid receptor binding: Danazol binds to multiple intracellular steroid receptors including:
This promiscuous receptor binding allows danazol to occupy nearly all steroid binding sites in target cells despite the presence of endogenous steroids 2.
Immunomodulatory Effects
Beyond hormonal actions, danazol demonstrates significant immunoregulatory properties:
Immunoglobulin suppression: Significantly decreases IgG, IgM, and IgA levels, as well as phospholipid and IgG isotope autoantibodies in patients with endometriosis 1
Cytokine modulation: Suppresses production of interleukin-1 beta (IL-1β) and tumor necrosis factor (TNF) by monocytes in a dose-dependent manner 4
Membrane effects: Intercalates into lipid bilayers of plasma membranes at approximately 100-fold higher concentrations than plasma levels, potentially altering antigen/receptor expression and reducing autoantibody binding 5
Disease-Specific Actions
In Hereditary Angioedema
Danazol increases levels of the deficient C1 esterase inhibitor (C1EI), which secondarily increases serum levels of the C4 component of the complement system 6, 1. This corrects the primary biochemical abnormality and prevents potentially fatal attacks of angioedema.
In Endometriosis
Danazol induces endometrial atrophy through:
- Creating a hypoestrogenic, hyperandrogenic environment (pseudo-menopause)
- Direct binding to androgen and progesterone receptors in endometriotic tissue
- Suppression of abnormal autoantibody production against endometrial antigens 1, 7, 8
Important Clinical Considerations
The androgenic properties produce characteristic side effects including weight gain, virilization, acne, altered libido, and lipid profile changes 6. These androgenic effects are dose-dependent and limit long-term use, though the pituitary-suppressive action is generally reversible within 60-90 days after discontinuation 1.
Danazol's lipophilic nature allows it to partition into cell membranes and distribute into deep tissue compartments, with membrane concentrations far exceeding plasma levels 5. This unique distribution pattern may explain its diverse biologic effects beyond simple hormonal suppression.